Visual Assessment for Non-Culprit Lesion Revascularization

There is evidence in favor of complete revascularization in the context of ST elevation MI with multivessel disease where primary PCI has been successful. 

Estimación visual para revascularizar las lesiones no culpables

However, the small print in these studies should be read carefully. Should revascularization be completed during index intervention, index hospitalization or after discharge? Should complete revascularization be based on visual assessment, quantitative angiography, intravascular imaging, invasive functional criteria, or stress test imaging? 

The latest studies tend to simplify: non-culprit lesions can be revascularized after primary PCI. 

The present study, recently published in JACC, follows the same idea: defining non-culprit lesions with quantitative angiography.

In 4041 patients from the COMPLETE study, non-culprit lesions were analyzed mostly with quantitative angiography (n=3851). 


Read also: Ticagrelor to Improve Venous Graft Patency.


The pre-specified analysis determined the impact of stenosis severity >60% vs. <60% by quantitative angiography on the primary end point of cardiovascular death or new MI.

The secondary end point was a combination of cardiovascular death, new MI and ischemia driven revascularization.

Primary end point was reduced in 2479 patients presenting >60% stenosis severity by quantitative angiography (2.5% vs. 4.2%; HR: 0.61; CI 95%: 0.47 to 0.79) but not in the 1372 patients with non-culprit stenosis severity <60% (3% vs 2.9%; HR 1.04, CI 95%; 072 to 1.5).


Read also: Same Contrast Dose, Different Risk of Kidney Injury, Depending on Procedure.


The secondary end point saw similar outcomes.

Conclusion

In patients undergoing ST elevation acute coronary syndrome with multivessel disease, complete revascularization reduces events when quantitative angiography of non-culprit lesions shows >60% stenosis severity. 

Título original: Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.

Referencia: Tej Sheth et al. J Am Coll Cardiol 2020;76:1277–86. https://doi.org/10.1016/j.jacc.2020.07.034.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...